Picture of CVS logo

CVSG CVS News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareAdventurousMid CapFalling Star

REG - CVS Group plc Goldman Sachs Group. - Holding(s) in Company





 




RNS Number : 3467V
CVS Group plc
02 December 2019
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i


1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

CVS Group plc

1b. Please indicate if the issuer is a non-UK issuer  (please mark with an "X" if appropriate)

Non-UK issuer


2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

X

An event changing the breakdown of voting rights


Other (please specify)iii:


3. Details of person subject to the notification obligationiv

Name

The Goldman Sachs Group, Inc.

City and country of registered office (if applicable)

Corporation Trust Center, 1209 Orange Street,

Wilmington DE 19801, USA

4. Full name of shareholder(s) (if different from 3.)v

Name


City and country of registered office (if applicable)


5. Date on which the threshold was crossed or reachedvi:

25/11/2019

27/11/2019


% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments
(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

0.04%

0.00%

0.04%

70,654,959

Position of previous notification (if

applicable)

4.35%

1.63%

5.98%


 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

ISIN code (if possible)

Number of voting rightsix

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00B2863827


29,933


0.04%






SUBTOTAL 8. A

29,933

0.04%

 

 

Expiration
date
x

Exercise/
Conversion Period
xi















 

 

Expiration
date
x

Exercise/
Conversion Period
xi

settlementxii
















SUBTOTAL 8.B.2



 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii


Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entity
xiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

The Goldman Sachs Group, Inc.




GSAM Holdings LLC




Goldman Sachs Asset Management, L.P.




10. In case of proxy voting, please identify:

Name of the proxy holder

N/A

The number and % of voting rights held

N/A

The date until which the voting rights will be held

N/A

 

 

 

 

 

11. Additional informationxvi

Please note, the total amount of voting rights have been rounded to 2 decimal places therefore there is a possibility of a rounding error.

 

General email contact:

gs-regops-emea-position-enquiries@gs.com

 

 

 

 

London

27/11/2019

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLLLFLFFELFIIA

Recent news on CVS

See all news